Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 5 The molar ratio of plasma cGMP (cyclic guanosine monophosphate) to cardiac natriuretic peptides before and after 14 weeks of treatment with candesartan cilexetil (closed columns) or placebo (open columns). ANOVA = analysis of variance; ANP = atrial natriuretic peptide; BNP = brain natriuretic peptide. *p < 0.05 vs. before with a two-way ANOVA by Scheffé F test.
|
